Terms: = Breast cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
98 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against breast cancer: In vitro and In silico Analysis.
Gupta K; Gautre P; Biharee A; Singh Y; Patil UK; Kumar S; Thareja S
Med Oncol; 2024 Feb; 41(4):81. PubMed ID: 38400892
[TBL] [Abstract] [Full Text] [Related]
3. The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes.
Awaad A; Olama ZA; El-Subruiti GM; Ali SM
Sci Rep; 2023 Dec; 13(1):22940. PubMed ID: 38135693
[TBL] [Abstract] [Full Text] [Related]
4. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
5. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes.
Levina A; Uslan C; Murakami H; Crans DC; Lay PA
Inorg Chem; 2023 Oct; 62(43):17804-17817. PubMed ID: 37858311
[TBL] [Abstract] [Full Text] [Related]
6. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract] [Full Text] [Related]
7. Regulation and clinical potential of telomerase reverse transcriptase (tert/htert) in breast cancer.
Yang R; Han Y; Guan X; Hong Y; Meng J; Ding S; Long Q; Yi W
Cell Commun Signal; 2023 Aug; 21(1):218. PubMed ID: 37612721
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value and immune landscapes of tert promoter methylation in triple negative breast cancer.
Lin F; Huang J; Zhu W; Jiang T; Guo J; Xia W; Chen M; Guo L; Deng W; Lin H
Front Immunol; 2023; 14():1218987. PubMed ID: 37575241
[TBL] [Abstract] [Full Text] [Related]
9. Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
Nilsson JN; Siikanen J; Condello V; Jatta K; Saini R; Hedman C; Ihre Lundgren C; Juhlin CC
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37352166
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear and Cytoplasmic htert, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant treatment in HER2-Enriched breast cancer.
Delmonico L; Bines J; Nascimento CMD; Fernandes PV; Barbosa IS; Ribeiro GB; de Paula BHR; Silvestre RT; Ornellas MHF; Alves G; Lage C
Curr Oncol; 2023 Apr; 30(4):4094-4109. PubMed ID: 37185424
[TBL] [Abstract] [Full Text] [Related]
11. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.
Lei T; Shi YQ; Chen TB
Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820
[TBL] [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of tert-butyl ester and ethyl ester prodrugs of L-γ-methyleneglutamic acid amides for cancer.
Khan MIH; Mahdi F; Penfornis P; Akins NS; Hossain MI; Kim SJ; Sulochana SP; Adam AT; Tran TD; Tan C; Paolo Claudio P; Paris JJ; Le HV
Bioorg Med Chem; 2023 Jan; 78():117137. PubMed ID: 36603398
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance.
Yuan X; Yuan H; Zhang N; Liu T; Xu D
Clin Transl Med; 2022 Nov; 12(11):e1111. PubMed ID: 36394204
[TBL] [Abstract] [Full Text] [Related]
14. The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Harris PE; Zhernosekov K
Front Endocrinol (Lausanne); 2022; 13():941832. PubMed ID: 36387893
[TBL] [Abstract] [Full Text] [Related]
15. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
[TBL] [Abstract] [Full Text] [Related]
16. Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells.
Chen H; Wang D; Fan L; Liu Z; Zhang W; Xu J; Liu Y
Sci Rep; 2022 Mar; 12(1):4545. PubMed ID: 35296801
[TBL] [Abstract] [Full Text] [Related]
17. Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
Malorni L; Tyekucheva S; Hilbers FS; Ignatiadis M; Neven P; Colleoni M; Henry S; Ballestrero A; Bonetti A; Jerusalem G; Papadimitriou K; Bernardo A; Seles E; Duhoux FP; MacPherson IR; Thomson A; Davies DM; Bergqvist M; Migliaccio I; Gebhart G; Zoppoli G; Bliss JM; Benelli M; McCartney A; Kammler R; De Swert H; Ruepp B; Fumagalli D; Maibach R; Cameron D; Loi S; Piccart M; Regan MM; ;
Eur J Cancer; 2022 Mar; 164():39-51. PubMed ID: 35172272
[TBL] [Abstract] [Full Text] [Related]
18. Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid cancer: A Large Cohort Prospective Study from a Single Institution.
Di Noia V; Pimpinelli F; Renna D; Barberi V; Maccallini MT; Gariazzo L; Pontone M; Monti A; Campo F; Taraborelli E; Di Santo M; Petrone F; Mandoj C; Ferraresi V; Ferretti G; Carlini P; Di Bella O; Conti L; La Malfa AM; Pellini R; Bracco D; Giannarelli D; Morrone A; Cognetti F
Clin Cancer Res; 2021 Dec; 27(24):6815-6823. PubMed ID: 34583970
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of the growing public interest in selective androgen receptor modulators.
Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
[TBL] [Abstract] [Full Text] [Related]
20. breast cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/Cas9 System: An Oncogenetics Perspective.
Singh DD; Verma R; Tripathi SK; Sahu R; Trivedi P; Yadav DK
Curr Top Med Chem; 2021; 21(31):2800-2813. PubMed ID: 34477520
[TBL] [Abstract] [Full Text] [Related]
[Next]
